Gilgamesh Pharma Inc.
through Mar 31, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Mar 24, 2026 · D | Mar 31, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $60,000,000 | $15,000,000 | $-45,000,000 |
| Reported amount sold | $60,000,000 | $2,250,000 | $-57,750,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $50,000 | $50,000 | $0 |
Earlier SEC source: 0002107396-26-000003 · Later SEC source: 0002107396-26-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $15,000,000
- Reported amount sold
- $2,250,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (4)
-
0002107396-26-000004D · Mar 31, 2026 · PharmaceuticalsOffering: $15,000,000Sold: $2,250,000
-
0002107396-26-000003D · Mar 24, 2026 · PharmaceuticalsOffering: $60,000,000Sold: $60,000,000
-
0002107396-26-000002D · Feb 4, 2026 · PharmaceuticalsOffering: $6,090,946Sold: $6,090,946
-
0002107396-26-000001D · Feb 4, 2026 · PharmaceuticalsOffering: $4,366,118Sold: $0